Lombardi Ronald M.'s Form 4 filing
Prestige Consumer Healthcare Inc. (PBH) · filed Nov 19, 2024
- Accession no.
- 0001104659-24-120554
- Filed
- Nov 19, 2024
- Trade date
- Nov 18, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $6.79M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lombardi Ronald M.CIK 0001507111 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2024 | Common Stock, par value $0.01 per share | MOption exerciseAcquired | +48,512 | $57.18 | +$2,773,916.16 | 369,464 | Direct | |
| Nov 18, 2024 | Common Stock, par value $0.01 per share | SSaleDisposed | −48,512 | $82.67F1 | −$4,010,487.04 | 320,952 | Direct | |
| Nov 18, 2024 | Common Stock, par value $0.01 per share | MOption exerciseAcquired | +33,725 | $56.11 | +$1,892,309.75 | 354,677 | Direct | |
| Nov 18, 2024 | Common Stock, par value $0.01 per share | SSaleDisposed | −33,725 | $82.41F2 | −$2,779,277.25 | 320,952 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2024 | Common Stock | MOption exerciseDisposed | −48,512 | $0.00 | $0 | 5,213 | Direct | |
| Nov 18, 2024 | Common Stock | MOption exerciseDisposed | −33,725 | $0.00 | $0 | 5,662 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $81.50 to $82.67.
Referenced by the price of 1 transaction in Table I.
- F2
Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $81.50 to $82.41.
Referenced by the price of 1 transaction in Table I.